Results 81 to 90 of about 1,361 (136)

LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models. [PDF]

open access: yesPharmaceutics
Podolski-Renić A   +8 more
europepmc   +1 more source

Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors. [PDF]

open access: yesTarget Oncol
Patel MR   +9 more
europepmc   +1 more source

Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial. [PDF]

open access: yesTarget Oncol
Hamilton EP   +13 more
europepmc   +1 more source

Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs. [PDF]

open access: yesNat Chem Biol
Sadagopan A   +7 more
europepmc   +1 more source

Genomics of ovarian cancers and the potential of precision medicine. [PDF]

open access: yesTher Adv Med Oncol
Jarratt A   +3 more
europepmc   +1 more source

Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective. [PDF]

open access: yesMed Sci Monit
Abramiuk M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy